Home » Topics » BioWorld Science

BioWorld Science
RSS

Advantagene and BMS enter clinical trial collaboration

April 30, 2018

DisperSol initiates phase II trials of DST-0509 in iron overload disorder

April 30, 2018

Tagrisso receives positive opinion in Europe for first-line EGFR-mutated NSCLC

April 30, 2018

INSYS initiates phase II study of cannabidiol oral solution for treatment of Prader-Willi syndrome

April 30, 2018

EMA's CHMP adopts positive opinion for Dzuveo

April 30, 2018

Biktarvy granted positive opinion in Europe

April 30, 2018

ITI-214, a potential candidate for the treatment of Parkinson's disease

April 30, 2018

Janssen monoclonal antibody JNJ-64164711 depletes Tregs in tumor samples

April 30, 2018

REGN-4659 demonstrates antitumor activity in vivo

April 30, 2018

Clinical study shows potential of ranolazine in paramyotonia congenita

April 30, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...